T2Bmeet
Q4 T2Bmeet @ Boston 2026
Tuesday, December 1st
4:30-7 p.m. ET
200 Clarendon St, Boston, MA 02116, USA
Register for T2Bmeet @ Boston
T2B Pro or T2B Student members: get your promo code here
Look for an automated confirmation email and calendar invite within one business day from our event management platform, Luma. If you do not receive it, check your spam folder or contact us at [email protected].
About our host
Novo Holdings
Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk and Novonesis and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seed, Venture, Growth, Planetary Health Investments and Principal Investments teams, Novo Holdings invests in life science companies at all stages of development. As of year-end 2025, Novo Holdings had total assets of €93 billion.